Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma

Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma

Purpose. This study aims to identify clinical and imaging prognosticators associated with the successful bridging or downstaging to liver transplantation (LT) in patients undergoing Yttrium-90 radioembolization (Y90-RE) for hepatocellular carcinoma (HCC). Methods. Retrospectively, patients with Y90-...

Full description

Bibliographic Details
Main Authors:	Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Nima Kokabi
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2021/9926704

Similar Items

Tuning Your RADIOembolization| Imaging-guidance of Yttrium-90 Radioembolization
by: Gordon, Andrew Christian
Published: (2016)

Side Effects of Yttrium-90 Radioembolization
by: Ahsun eRiaz, et al.
Published: (2014-07-01)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
by: Lee VHF, et al.
Published: (2015-11-01)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
by: Aman Saini, et al.
Published: (2019-01-01)

Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma
by: B. Zapote Hernández, et al.
Published: (2020-09-01)

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
by: Minzhi Xing, et al.
Published: (2018-01-01)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
by: Murthy R. Chamarthy, et al.
Published: (2012-01-01)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
by: Meyer C, et al.
Published: (2017-09-01)

Yttrium-90 radioembolization in patients with hepatocellular carcinoma who have previously received sorafenib
by: Nitesh eRana, et al.
Published: (2013-12-01)

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.
by: Zhihong Weng, et al.
Published: (2013-01-01)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
by: Teyateeti A, et al.
Published: (2020-09-01)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
by: Hoda Rezaei Roshan, et al.
Published: (2015-01-01)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
by: Sen Lu, et al.
Published: (2021-02-01)

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
by: Michael Köhler, et al.
Published: (2019-12-01)

Yttrium-90 radioembolization for the treatment of unresectable liver cancer: Results of a single center
by: Özhan Özgür, et al.
Published: (2014-03-01)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
by: Gary W. Nace, et al.
Published: (2011-01-01)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
by: Jonathan M. Loree, et al.
Published: (2016-01-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
by: Cappelli A, et al.
Published: (2014-11-01)

Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
by: Sonja Gordic, et al.
Published: (2019-05-01)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
by: Zhen Y, et al.
Published: (2019-06-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
by: Simon Lemieux, et al.
Published: (2021-01-01)

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
by: Mostafa Mohamed, MD, et al.
Published: (2016-01-01)

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
by: Francesco Somma, et al.
Published: (2019-01-01)

A Woman with Black Beads in Her Stomach: Severe Gastric Ulceration Caused by Yttrium-90 Radioembolization
by: Indu S. Voruganti, et al.
Published: (2018-01-01)

Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres
by: Chien-An Liu, et al.
Published: (2021-04-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
by: M. Pracht, et al.
Published: (2013-01-01)

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities
by: Jens Hemmingsson, MS, et al.
Published: (2018-07-01)

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.
by: Mattijs Elschot, et al.
Published: (2013-01-01)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
by: Nicholas Pigg, et al.
Published: (2020-02-01)

Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer
by: Andre De Souza, et al.
Published: (2015-01-01)

Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Lei Liang, et al.
Published: (2020-03-01)

Non-target activity detection by post-radioembolization yttrium-90 PET/CT: Image assessment technique and case examples
by: Yung Hsiang eKao, et al.
Published: (2014-02-01)

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
by: Tommaso Depalo, et al.
Published: (2021-10-01)